How Long Does PCP Stay in Your System?

PCP stays in your system anywhere from a few days to several weeks, depending mainly on the test used and how often the drug is taken. Most urine tests detect phencyclidine for about 5 to 14 days after the last dose.

Hair testing pushes that window much further, while blood and saliva clear the fastest. Heavy or long-term use stretches every one of these timelines.

So how long does PCP really stay in your system, and what changes that answer from one person to the next?

Key Takeaways

• Detection windows differ by test: Phencyclidine clears blood within roughly 24 hours but stays in urine for 5 to 14 days and in hair for up to 90 days.
• PCP carries a long, variable half-life: Laboratory pharmacology data place the elimination half-life at 7 to 46 hours, and Cook and colleagues (1982) measured a mean near 17.6 hours, with some people exceeding two days.
• Standard immunoassays misfire on PCP: Rengarajan and Mullins (2013) linked tramadol, dextromethorphan, alprazolam, clonazepam, and carvedilol to false-positive phencyclidine urine screens.
• PCP ranks as a Schedule II controlled substance: The Drug Enforcement Administration classifies phencyclidine alongside high-abuse-potential drugs, reflecting its dependence risk.
• Body fat extends the window: Lipophilic phencyclidine stores in fatty tissue and releases slowly, lengthening detection in frequent users.

What Is PCP and How Long Is It Detectable?

PCP, short for phencyclidine, is a dissociative drug that standard urine screens detect for about 5 to 14 days after the last use. The compound acts as an N-methyl-D-aspartate (NMDA) receptor antagonist, producing detachment, distorted perception, and numbness.

How PCP Works in the Body

Phencyclidine blocks NMDA receptors in the brain, disrupting glutamate signaling and creating the drug’s hallmark sense of separation from reality. Clinicians classify phencyclidine (PCP) as a Schedule II controlled substance because chronic exposure drives tolerance and dependence.

• Common forms and names: PCP appears as a powder, liquid, or tablet and circulates under the street name “angel dust.” Users smoke, swallow, snort, or inject it.
• Onset and duration of effects: Effects begin within minutes when smoked and can last several hours, far shorter than the drug’s full detection window.

How Drug Tests Identify PCP

Drug panels screen for phencyclidine using an immunoassay that flags the molecule through antibody binding. The standard SAMHSA 5-panel and expanded 10-panel and 11-panel screens all include PCP as a target analyte.

• Screening versus confirmation: An initial immunoassay gives a presumptive result, and gas chromatography-mass spectrometry (GC-MS) or LC-MS/MS confirms a true positive with high accuracy.
• Why confirmation matters: Immunoassays cross-react with unrelated medications, so a confirmatory test separates genuine PCP use from look-alike compounds.

How the Body Metabolizes and Clears PCP

The body clears phencyclidine slowly because the drug is highly fat-soluble and lingers in tissue long after effects fade. The liver breaks down PCP, and the kidneys excrete the remainder, with clearance speed shaping every detection window.

Half-Life and Distribution

PCP carries an elimination half-life of 7 to 46 hours, meaning the body removes half the dose across that span. Cook and colleagues (1982) measured a mean half-life near 17.6 hours and a large volume of distribution of 6.2 liters per kilogram, confirming that phencyclidine spreads widely into fatty tissue.

• Lipophilic storage: Fat-soluble phencyclidine accumulates in adipose tissue and the brain, then releases gradually and prolongs the time the drug remains measurable.
• Smoked metabolite: Smoking PCP produces phenylcyclohexene in the vapor, a marker that reflects the inhaled route of use.

Liver and Kidney Elimination

The liver metabolizes phencyclidine through hydroxylation by cytochrome P450 enzymes before the kidneys flush the byproducts. Cook and colleagues (1982) found that, at normal urine pH, renal excretion handles under 10 percent of total clearance, while strong urinary acidification sharply increases kidney clearance through ion trapping.

• Urine pH effect: Acidic urine traps charged phencyclidine in the kidney tubules and speeds excretion, which is why pH influences how fast the drug leaves the body.
• Individual metabolism: A faster metabolic rate shortens the window, while slowed clearance lengthens how long PCP affects the brain and body.

PCP Detection Windows by Drug Test Type

PCP detection windows range from roughly one day in blood to 90 days in hair, with urine sitting in the middle at 5 to 14 days. The numbered timeline below lists each method by how soon it detects use and how long the window stays open.

1. Blood (up to about 24 hours): Phencyclidine appears in blood within minutes of use, peaks quickly, and usually clears within 24 hours, though heavy use can extend this slightly.
2. Saliva (about 1 hour to 3 days): Oral fluid tests detect PCP soon after use and remain positive for one to three days, making saliva a short-window option.
3. Urine (about 5 to 14 days): Urine immunoassays detect phencyclidine within hours of use through 5 to 14 days, and frequent or high-dose use can extend detection toward 30 days.
4. Hair (up to 90 days): Hair follicle testing records PCP from roughly a week after use through 90 days, giving the longest record of past exposure.

Urine remains the most common screen for workplace and clinical testing, so the standard urine drug screening drives most real-world detection. The table below compares the typical windows side by side.

Test type	Detection starts	Detection window	Best use
Blood	Within minutes	Up to ~24 hours	Recent use, emergency settings
Saliva	~1 hour	1 to 3 days	Recent use, roadside screening
Urine	Within hours	5 to 14 days (up to 30 with heavy use)	Workplace and clinical screening
Hair	~7 days	Up to 90 days	Long-term use history

What Affects How Long PCP Stays in Your System

Personal and dose-related factors determine where each person falls inside the broad PCP detection ranges. The variables below all push phencyclidine clearance faster or slower.

• Frequency and dose: Repeated or high-dose phencyclidine use saturates fatty tissue and builds tolerance, extending detection well beyond a single recreational dose.
• Body composition: Higher body fat stores more lipophilic PCP, releasing it slowly and lengthening the urine and hair windows.
• Metabolic rate: A faster liver metabolism clears phencyclidine sooner, while slowed hepatic function delays elimination.
• Urine pH and hydration: Acidic urine accelerates renal excretion of phencyclidine, and hydration status shifts concentration on a urine screen.
• Route of use: Smoked and injected phencyclidine reach peak levels faster than swallowed doses, which changes when the detection window opens.

Signs of PCP Use and Overdose Warning Signs

Recognizing phencyclidine intoxication helps separate active effects from lingering detection on a test. The three tiers below move from common signs to medical emergencies to lasting damage.

Common Signs of Recent PCP Use

Recent phencyclidine use produces dissociation and physical changes that observers can often spot. These signs reflect active intoxication rather than residual traces on a drug screen.

• Emotional and perceptual changes: PCP triggers euphoria, a strong sense of detachment, numbness, and distorted perception of sound and sight.
• Physical signs: Phencyclidine elevates blood pressure and heart rate and often produces slurred speech and horizontal or vertical nystagmus, a rapid involuntary eye movement.

Severe Effects and Overdose Warning Signs

High doses of phencyclidine drive a medical emergency that demands immediate care. The numbered signs below warrant a call to 911 without delay.

1. Seizures or convulsions: Phencyclidine overstimulates the nervous system and can trigger seizures even in people with no prior history.
2. Extreme agitation or violent behavior: PCP fuels aggression and unpredictable behavior that endangers the person and others.
3. Dangerous hyperthermia: Phencyclidine raises body temperature to harmful levels, threatening organ function.
4. Rhabdomyolysis: Severe muscle breakdown releases proteins that injure the kidneys and can cause kidney failure.
5. Coma or respiratory depression: High doses suppress breathing and consciousness, a life-threatening combination.

Long-Term Effects of Chronic PCP Use

Long-term phencyclidine use damages cognition and mental health beyond any single detection window. These effects can persist long after the drug clears the body.

• Persistent psychiatric symptoms: Chronic PCP use drives lasting psychosis, paranoia, and depression that may continue between periods of use.
• Cognitive and speech problems: Repeated phencyclidine exposure impairs memory, attention, and speech, and dependence develops with continued use.

PCP vs Ketamine and DXM: Detection Differences and False Positives

PCP, ketamine, and dextromethorphan all act on NMDA receptors, yet they behave very differently on a drug screen. Understanding these differences explains why a positive PCP result sometimes reflects another substance entirely.

How the Three Dissociatives Compare

Phencyclidine clears far more slowly than ketamine or dextromethorphan, which carry much shorter half-lives. The table below contrasts the three dissociatives by half-life, urine window, and screen behavior.

Substance	Half-life	Typical urine detection	Standard panel behavior
PCP (phencyclidine)	7 to 46 hours	5 to 14 days (up to 30 with heavy use)	Direct target on 5-panel screens
Ketamine	~2.5 to 3 hours	1 to 3 days	Not a standard target; needs a specific test
Dextromethorphan (DXM)	~3 to 4 hours	1 to 2 days	Can cross-react and trigger a false-positive PCP result

Medications That Cause False-Positive PCP Results

Several common medications cross-react with PCP immunoassays and produce false-positive results that confirmatory testing then clears. Rengarajan and Mullins (2013) found that tramadol, dextromethorphan, alprazolam, clonazepam, and carvedilol significantly raised the odds of a false-positive phencyclidine urine screen.

• Antidepressants: Venlafaxine and its active metabolite desvenlafaxine are the most documented prescription triggers of false-positive PCP screens.
• Cough and allergy medicines: Dextromethorphan and the antihistamine diphenhydramine cross-react with PCP antibodies on immunoassay screens.
• Other detection comparisons: Antidepressants such as escitalopram and trazodone carry their own detection windows and screen behavior worth checking before testing.

A quick note on designer dissociatives clarifies a common search question. The research chemical 3-MeO-PCP is a distinct compound that standard PCP immunoassays do not reliably detect, since it requires specialized LC-MS/MS testing to identify.

How PCP Differs From Other Recreational Drugs

Phencyclidine differs from stimulants and entactogens in both its effects and its screen targets. The dissociative profile of PCP separates it from drugs like MDMA, which the amphetamine portion of a panel detects instead.

• Different receptor action: PCP blocks NMDA receptors and produces detachment, while MDMA floods serotonin and produces stimulation and emotional closeness.
• Different panel targets: A standard screen reads phencyclidine on its own PCP line, separate from the amphetamine and opiate targets.

Treatment for PCP Use Disorder

Treatment for phencyclidine use disorder combines behavioral therapy, supportive medication, and care for co-occurring conditions, since no medication specifically reverses PCP dependence. Clinicians screen severity with the Drug Abuse Screening Test (DAST-10), a 10-item self-report tool that measures drug-related problems over the past 12 months, where higher scores signal greater severity.

Evidence-Based Therapy and Medication

Behavioral therapy forms the first line of care for phencyclidine use disorder because it targets the thoughts and habits that sustain use. Supportive medications then manage acute symptoms and any co-occurring psychiatric conditions.

• First-line therapies: Cognitive behavioral therapy (CBT), contingency management, and motivational interviewing address cravings, triggers, and motivation for sustained recovery.
• Pharmacological support: No medication is approved for PCP use disorder, so clinicians use benzodiazepines such as lorazepam and diazepam to control agitation and seizures during acute intoxication, with antipsychotics used cautiously for severe psychosis.
• Adjunct and second-line care: Trauma-focused therapy, family therapy, and group counseling reinforce relapse prevention alongside long-term addiction recovery.
• Emerging treatments: N-acetylcysteine (NAC) is under investigation for reducing cravings in substance use disorders, and transcranial magnetic stimulation (TMS) remains an investigational option for craving reduction.

Treatment at The Grove Estate

The Grove Estate treats phencyclidine use disorder through medically supervised detox, residential rehabilitation, and integrated care for co-occurring conditions at its Indiana sanctuary setting. Each program follows ASAM level of care criteria and a trauma-informed, non-coercive approach.

Medically Supervised Detox

The Grove Estate manages PCP withdrawal through on-site detox with continuous medical oversight. The detox team uses physician-prescribed medications and 24-hour registered nurse monitoring to keep clients safe as phencyclidine clears the body during medically supervised detox.

Residential Rehabilitation

Residential rehabilitation at The Grove Estate provides a 24-hour structured environment after detox stabilizes the client. Licensed clinicians lead individual and group counseling that targets the behaviors driving phencyclidine use.

Dual Diagnosis Care

The Grove Estate treats phencyclidine-related psychosis and mood symptoms through integrated dual diagnosis care. A psychiatric provider conducts evaluations and weekly clinical rounds to address co-occurring mental health conditions alongside substance use.

Care for Working Professionals

The Grove Estate tailors treatment to working professionals who need a cohesive, discreet recovery environment. The program places clients alongside peers facing similar pressures, reinforcing accountability through shared experience.

According to Dr. Steven Schneider, Medical Director at The Grove Estate, “Because phencyclidine stores in fatty tissue and releases slowly, clients often test positive and feel lingering effects well after their last use, which is why medical supervision through the full clearance period matters so much.” Dr. Schneider, a Diplomate and Fellow of the American Board of Psychiatry and Neurology, leads psychiatric care across the program.

Frequently Asked Questions

Can you speed up how fast PCP leaves your system?

No reliable method flushes phencyclidine out faster, and detox drinks do not work as advertised. Only the liver and kidneys clear PCP, and that process follows the drug’s half-life regardless of water intake or commercial products. Time and individual metabolism set the pace.

How long do PCP’s effects last compared with its detection window?

The felt effects of phencyclidine usually last a few hours to a day, far shorter than the detection window. A urine test can flag PCP for 5 to 14 days after the high has fully worn off, so feeling normal does not mean the drug has cleared.

Can secondhand PCP smoke cause a failed drug test?

Secondhand phencyclidine smoke is very unlikely to produce a positive test at standard cutoff levels. Drug screens set thresholds that filter out trace incidental exposure, so a confirmed positive almost always reflects direct use rather than passive contact.

How quickly can someone become dependent on PCP?

Dependence on phencyclidine can develop within weeks of regular use as the brain adapts to repeated NMDA receptor blockade. The speed varies with dose and frequency, and tolerance often builds first, prompting larger amounts that accelerate dependence.

Is PCP used in any legal or medical setting today?

PCP has no current legal medical use in humans and is banned from clinical practice. Doctors abandoned phencyclidine as an anesthetic decades ago because patients developed delirium and hallucinations after surgery, leaving only illicit recreational use today.

What should you tell a testing lab if you take medications that cross-react with PCP?

Tell the lab about every prescription and over-the-counter medication before testing, especially venlafaxine, dextromethorphan, or tramadol. Disclosed medications let the lab order confirmatory GC-MS testing, which distinguishes a genuine phencyclidine positive from a cross-reacting drug.

How long is PCP detectable in a newborn after prenatal exposure?

Phencyclidine can be detected in a newborn’s meconium, which records exposure across the later months of pregnancy. Meconium testing offers a far longer detection window than infant urine, since it accumulates substances over time rather than reflecting only recent use.

Do at-home urine drug tests reliably detect PCP?

Most at-home urine kits screen for phencyclidine but only give a presumptive result. These immunoassay tests can return false positives from cross-reacting medications, so any positive needs laboratory GC-MS confirmation before it is treated as accurate.

References

1. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). American Psychiatric Publishing.
2. Cook, C. E., Brine, D. R., Jeffcoat, A. R., Hill, J. M., Wall, M. E., Perez-Reyes, M., and Di Giuseppi, S. R. (1982). Phencyclidine disposition after intravenous and oral doses. Clinical Pharmacology and Therapeutics, 31(5), 625-634.
3. Rengarajan, A., and Mullins, M. E. (2013). How often do false-positive phencyclidine urine screens occur with use of common medications? Clinical Toxicology, 51(6), 493-496.
4. Saitman, A., Park, H. D., and Fitzgerald, R. L. (2014). False-positive interferences of common urine drug screen immunoassays: A review. Journal of Analytical Toxicology, 38(7), 387-396.
5. Bey, T., and Patel, A. (2007). Phencyclidine intoxication and adverse effects: A clinical and pharmacological review of an illicit drug. California Journal of Emergency Medicine, 8(1), 9-14.
6. Hadland, S. E., and Levy, S. (2016). Objective testing: Urine and other drug tests. Child and Adolescent Psychiatric Clinics of North America, 25(3), 549-565.
7. National Institute on Drug Abuse. (2024). Hallucinogens DrugFacts. Retrieved from https://nida.nih.gov/publications/drugfacts/hallucinogens
8. MedlinePlus, National Library of Medicine. (2024). Substance use – phencyclidine (PCP). Retrieved from https://medlineplus.gov/ency/patientinstructions/000797.htm
9. U.S. Drug Enforcement Administration. (2020). Phencyclidine (PCP) drug fact sheet. Retrieved from https://www.dea.gov/factsheets/pcp